Chris Wilson > Goodwin > Boston, United States > Lawyer Profile

Goodwin houses a broad team known for its varied specialism, which spans contentious healthcare fraud work, and pharmacy and healthtech acquisitions. David Cappillo and Chris Wilson jointly lead the team from Boston, while William Jackson leads from Washington DC. Capillo is particularly active within the healthcare tech space, representing both tech and health companies, Wilson handles the full spectrum of issues which arise at the intersection between healthcare and private equity law, and Jackson is a seasoned litigator who often acts in major commercial cases. Miranda Hooker in Boston and Ilene Albala in Washington DC are key figures within the team known for their vast experience in FCA, AKS, and HIPAA investigations, and both women’s health initiatives and qui tam cases respectively. Philadelphia’s John Jones is noted for his expertise in private equity within healthcare, often advising health systems, and both private equity and venture capital firms. In the New York office, Roger Cohen utilizes his deep knowledge of tech to assist investors and health service clients with M&A and healthcare delivery issues.

Goodwin‘s ‘best-in-class‘ private equity practice combines deep expertise in middle-market and growth equity transactions with a strong global presence. The firm advises sponsors and investors on structuring complex deals, fund formations, and buyouts. Helming the practice from Boston is John LeClaire, a seasoned partner valued by both financial sponsors and growth companies who rely on his advice regarding M&A, investments, and restructurings. Co-chair Brian McPeake has an extensive cross-border practice and covers a range of sectors including financial services, fintech, software and healthcare from San Francisco. New York co-head Chris Nugent underpins his transactional pedigree with skill in corporate governance, while Chris Wilson is noted for his healthcare and tech-focused practice. Joshua Klatzkin is well-regarded for his work across small-cap and mid-market buyouts and is another key name for early stage growth instructions. Amy Keller also comes recommended for her broad practice.